Clinical expertise,
compassionate care

Dr. Kee Ong

BMedSci, MBBS, MMed(RH & HG) Sydney, FRANZCOG


Queensland and New South Wales Medical Board

Professional memberships

  • Fertility Society Australia
  • European Society of Human Reproduction
  • America Society of Reproductive Medicine
  • Australian Gynaecology Endoscopy Society
  • Royal Australian and New Zealand College of Obstetrician and Gynaecologist

Private Hospital Visiting Rights

  • Allamanda Private Hospital

Particular Interests

  • PCOS
  • Recurrent Miscarriages
  • Recurrent IVF failures and Reproductive surgery
  • Endometriosis


Journal articles

  • KJ Ong, E Theodoru, W Ledger (2006) Long-term consequences of polycystic ovarian syndrome, Current Obstetrics and Gynaecology 16, 333-336.
  • SW Seng, KJ Ong, WL Ledger (2006) Gonadotropin-releasing hormone antagonist in in vitro fertilisation, Women’s Health 2:881-888.
  • KJ Ong, M Metwally, WL Ledger (2007). Uterine artery embolisation and future fertility, Women’s Health 3(4): 449-453
  • M Metwally, KJ Ong, WL Ledger, TC Li (2008). Does high body mass index increase the risk of miscarriage after spontaneous and assisted conception? A meta-analysis of the evidence. Fertility and Sterility 90(3) 714-726
  • KJ Ong, TC Li (2008) An Overview of Management of fibroids, Journal Pediatrics Obstetrics and Gynaecology Jan 29-33.
  • SD Fleming, RS Ilad, A-MG Griffin, Y Wu, KJ Ong, HC Howard and RJ Aitken (2008) Prospective controlled trial of an electrophoretic method of sperm preparation for assisted reproduction: comparison with density gradient centrifugation. Human Reproduction 23(12) 2646-2651
  • Submitted for publication:C Coughlan, KJ Ong, Q Wang, R Cutting, H Sallam, TC Li (2010) Recurrent Implantation Failure (Human Reproduction Update)


  • KJ Ong, TC Li. Chapter 13: Complications of Assisted Reproductive Technology. P O’Donovan (ed) Complications in Gynaecological Surgery (Springer Science) 2008.
  • KJ Ong, S Seng. Chapter 2: Ovarian stimulation. Scientists involved in Reproductive Technology textbook. 2009.

Presentations at Local, National and International Conferences

  • Sep 2003: Obstetrics and Gynaecology in Rural Practice, Queensland Rural Medical Support Agency, Brisbane, Australia.
  • Mar 2004: Embryo Transfer Technique, 2nd Certified Reproductive Endocrinology and Infertility Trainee Conference, Melbourne, Australia.
  • Oct 2004: Efficacy of GnRH antagonist compared to GnRH agonist in AR, Fertility Society Australia (FSA) Conference, Adelaide, Australia.
  • Sep 2005: Experience of rapid assisted reproductive technology (ART) treatment in cancer patients prior to chemotherapy between 1998-2005, FSA Conference, Christchurch, New Zealand.
  • Sep 2005: Methotrexate treatment in ectopic pregnancies, FSA Conference, Christchurch, New Zealand.
  • Nov 2006: HRT and Osteoporosis, Western Sydney Menopause Day, Sydney, Australia.
  • Nov 2006: Evolution of GnRH antagonist treatment to fixed day regime increases pregnancy and implantation rates, FIGO, Kuala Lumpur, Malaysia.
  • Oct 2008: FNA (Fertility Society Australia Conference) – Optimizing Ovarian stimulation
  • Oct 2010: Pharmacy Assistant National Conference 2010. – Preconceptional Care (It takes two to Tango)


  • Sep 2005: Cornual pregnancy resulting from frozen embryo transfer in a woman with a history of bilateral salpingectomies, FSA Conference, Christchurch, New Zealand
  • Sep 2007: Outcomes of Follicular Reduction (FR) at stimulated intrauterine insemination (SIUI) in a nested case controlled study, FSA Conference, Hobart, Tasmania
  • Sep 2007: Medical management of ectopic pregnancy after IVF treatment with extremely high hcG, FSA Conference, Hobart, Tasmania

Involvement in Multicentre Trial

  • 2006: Ferring Ltd study: Randomised comparison of recombinant versus urinary derived gonadotropin for controlled ovarian hyperstimulation in GnRH antagonist regulated cycles (Co-Investigator)
  • 2006: Akzo Nobel (Organon): Phase III randomised, double-blind, active-controlled, non-inferiority clinical trial of a single injection of Org 36286 to induce multi-follicular development for controlled ovarian stimulation (Co-Investigator)
  • 2006:Pfizer Ltd: Proteomic analysis of endometriosis and putative serum markers of disease progression (Co-Investigator)

Research Grants

Sep 2005: Fertility Society of Australia; Co-Investigator: Sperm preparation for ART using the Gradiflow CS10, AUD$7,000